Krystal Biotech buy Chardan Capital
Start price
18.12.24
/
50%
€151.90
Target price
18.12.25
€202.14
Performance (%)
-8.00%
Price
16:37
€139.75
Summary
This prediction is currently active. With a performance of -8.00%, the BUY prediction by Chardan_Capital is trending in the wrong direction. This prediction currently runs until 18.12.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 13.709% | 13.709% |
| iShares Core DAX® | -0.234% | -2.570% |
| iShares Nasdaq 100 | 2.073% | 5.092% |
| iShares Nikkei 225® | 1.244% | 5.873% |
| iShares S&P 500 | 1.133% | 3.401% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat